On-time vaccine receipt in the first year does not adversely affect neuropsychological outcomes

Pediatrics

Volumn 125, Issue 6, 2010, Pages 1134-1141

  Smith, Michael J ^a   Woods, Charles R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Neurodevelopmental; Public health; Vaccine safety; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; CHILD; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONFOUNDING VARIABLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANCY; LIFE; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; PARENT; PERFORMANCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; TIME; UNIVARIATE ANALYSIS; VACCINATION;

FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; MENTAL PROCESSES; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; SAFETY; TIME FACTORS; VACCINATION;

EID: 77953063997     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-2489     Document Type: Article

References (27)

1. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18): 2155-2163
2. Chen RT. Vaccine risks: real, perceived and unknown. Vaccine. 1999;17(suppl 3): S41-S46
3. Gerber JS, Offit PA. Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis. 2009;48(4):456-461
4. Gellin BG, Maibach EW, Marcuse EK. Do parents understand immunizations? A national telephone survey. Pediatrics. 2000;106(5): 1097-1102
5. Smith PJ, Chu SY, Barker LE. Children who have received no vaccines: who are they and where do they live? Pediatrics. 2004; 114(1):187-195
6. Janssen AP, Tardif RR, Herring RM, Smith MJ. Physician's Perceptions of Current Vaccine Issues. Washington, DC: US Department of Health and Human Services; 2008
7. Offit PA, Moser CA. The problem with Dr Bob's alternative vaccine schedule. Pediatrics. 2009;123(1). Available at: www. pediatrics.org/cgi/ content/full/123/1/e164
8. Glanz JM, McClure DL, Magid DJ, et al. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics. 2009;123(6):1446-1451
9. NVAC Vaccine Safety Working Group Draft Report. Available at: www.hhs.gov/nvpo/ nvac/documents/NVACVaccineSafetyWG Report041409.pdf. Accessed July 31, 2009
10. Davis RL, Kramarz P, Bohlke K, et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink Project. Arch Pediatr Adolesc Med. 2001; 155(3):354-359
11. Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112(4): 815-820 (Pubitemid 37248689)
12. Hambidge SJ, Glanz JM, France EK, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006;296(16):1990-1997
13. Mell LK, Ogren DS, Davis RL, et al. Compliance with national immunization guidelines for children younger than 2 years, 1996-1999. Pediatrics. 2005;115(2): 461-467
14. DeStefano F, Mullooly JP, Okoro CA, et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 2001;108(6). Available at: www. pediatrics.org/cgi/content/full/108/6/e112
15. Thompson WW, Price C, Goodson B, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med. 2007;357(13):1281- 1292
16. Centers for Disease Control and Prevention. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1994;43(RR-1): 1-38
17. Centers for Disease Control and Prevention. Recommended childhood immunization schedule-United States, 1997. MMWR Morb Mortal Wkly Rep. 1997;46(2): 35-40
18. Luman ET, Barker LE, Shaw KM, McCauley MM, Buehler JW, Pickering LK. Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed. JAMA. 2005;293(10): 1204-1211
19. Price C, Goodson B, Stewart G. Infant Environmental Exposure to Thimerosal and Neuropsychological Outcomes at Ages 7 to 10 Years. Technical Report. Vol I. Bethesda, MD: Abt; 2007
20. Grandjean P, Budtz-Jorgensen E, White RF, et al. Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. Am J Epidemiol. 1999;150(3): 301-305 (Pubitemid 29355129)
21. Davidson PU, Kost J, Myers GJ, Cox C, Clarkson TW, Shamlaye CF. Methylmercury and neurodevelopment: reanalysis of the Seychelles Child Development Study outcomes at 66 months of age. JAMA. 2001;285(10): 1291-1293 (Pubitemid 32216142)
22. Bradley RH, Caldwell BM. The HOME inventory and family demographics. Dev Psychol. 1984;20(2):315-320
23. Totsika V, Sylva K. The Home Observation for Measurement of the Environment revisited. Child Adolesc Ment Health. 2004; 9(1):25-35
24. Centers for Disease Control and Prevention. Pertussis-United States, 2001-2003. MMWR Morb Mortal Wkly Rep. 2005;54(50): 1283-1286
25. Strine TW, Luman ET, Okoro CA, McCauley MM, Barker LE. Predictors of age-appropriate receipt of DTaP dose 4. Am J Prev Med. 2003; 25(1):45-49
26. Chen RT, Glasser JW, Rhodes PH, et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics. 1997;99(6): 765-773
27. Offit PA, Quarles J, Gerber MA, et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics. 2002;109(1): 124-129 (Pubitemid 34049436)